Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)

Metastatic neuroendocrine tumors (gastrinomas) have a poor prognosis. Octreotide can reduce gastrin levels and alleviate hormonal symptoms, and possibly slow tumor growth as well. No drugs were available except streptozocin for the treatment of metastatic pancreatic neuroendocrine tumor (PNET) in 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraide, Sakura, Ono, Sadahide, Kato, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471786/
https://www.ncbi.nlm.nih.gov/pubmed/28626400
http://dx.doi.org/10.1159/000475463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471786/
https://www.ncbi.nlm.nih.gov/pubmed/28626400
http://dx.doi.org/10.1159/000475463

Ejemplares similares